Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety

Molecular and Clinical Oncology ◽

10.3892/mco.2018.1672 ◽

2018 ◽

Cited By ~ 3

Author(s):

Ferdinando Riccardi ◽

Giuseppe Colantuoni ◽

Anna Diana ◽

Carmela Mocerino ◽

Giacomo Carten� ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Retrospective Study ◽

Combination Treatment ◽

Southern Italy ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Campania Region ◽

Cancer Centers ◽

Hormone Receptor Positive

Download Full-text

Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysis

Current Problems in Cancer ◽

10.1016/j.currproblcancer.2020.100606 ◽

2020 ◽

Vol 44 (6) ◽

pp. 100606 ◽

Cited By ~ 1

Author(s):

Yiqun Han ◽

Jiayu Wang ◽

Zijing Wang ◽

Binghe Xu

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Metastatic Breast Cancer ◽

Hormone Receptor ◽

Meta Analysis ◽

Metastatic Breast ◽

Mtor Inhibitors ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Hormone Receptor Positive

Download Full-text

50P Efficacy and safety analysis of pyrotinib in lapatinib resistant HER2-positive metastatic breast cancer: A retrospective study

Annals of Oncology ◽

10.1016/j.annonc.2020.10.070 ◽

2020 ◽

Vol 31 ◽

pp. S1262

Author(s):

Y. Hua ◽

F. Yang ◽

Y. Yang ◽

S. Bao ◽

C. Sun ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Retrospective Study ◽

Metastatic Breast ◽

Safety Analysis ◽

Efficacy And Safety ◽

Her2 Positive

Download Full-text

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

BMC Cancer ◽

10.1186/s12885-019-5668-3 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 8

Author(s):

Zongbi Yi ◽

Fei Ma ◽

Binliang Liu ◽

Xiuwen Guan ◽

Lixi Li ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Retrospective Study ◽

Hormone Receptor ◽

Pik3ca Mutation ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Potential Efficacy

Download Full-text

Efficacy and safety of low-dose everolimus combined with endocrine drugs for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer

Annals of Translational Medicine ◽

10.21037/atm-21-4273 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Hui-Qiang Zhang ◽

Jin-Mei Zhou ◽

Shao-Hua Zhang ◽

Li Bian ◽

Jin-Yi Xiao ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Low Dose ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

A Retrospective Study of Efficacy and Safety of Albumin-bound paclitaxel in Metastatic Breast Cancer

World Journal of Oncology ◽

10.14740/wjon865w ◽

2014 ◽

Vol 5 (5-6) ◽

pp. 204-209 ◽

Cited By ~ 4

Author(s):

Rajesh Kumar Singh ◽

Sangeeta Pankaj ◽

Sumit Kumar ◽

Vamsi Raj Kota

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Retrospective Study ◽

Metastatic Breast ◽

Efficacy And Safety

Download Full-text

53O_PR Efficacy and safety of palbociclib plus fulvestrant in Asian women with hormone receptor-positive (HR+)/human epidermal growth factor-2 negative (HER2-) metastatic breast cancer (MBC) that progressed on prior endocrine therapy (ET)

Annals of Oncology ◽

10.1093/annonc/mdv519.02 ◽

2015 ◽

Vol 26 ◽

pp. ix16

Author(s):

J. Ro ◽

S.-A. Im ◽

N. Masuda ◽

Y.-H. Im ◽

K. Inoue ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Hormone Receptor ◽

Metastatic Breast ◽

Asian Women ◽

Efficacy And Safety ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial

International Journal of Cancer ◽

10.1002/ijc.31738 ◽

2018 ◽

Vol 144 (4) ◽

pp. 877-885 ◽

Cited By ~ 7

Author(s):

Hans Tesch ◽

Oliver Stoetzer ◽

Thomas Decker ◽

Christian M. Kurbacher ◽

Frederik Marmé ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive ◽

Phase Iiib ◽

Epidermal Growth

Download Full-text

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

BMC Cancer ◽

10.1186/s12885-017-3846-8 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 7

Author(s):

Sakura Iizumi ◽

Tatsunori Shimoi ◽

Natsuko Tsushita ◽

Seiko Bun ◽

Akihiko Shimomura ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Retrospective Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Eligibility Criteria

Download Full-text

Abstract P4-13-01: PALOMA3: Phase 3 trial of fulvestrant with or without palbociclib in pre- and postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that progressed on prior endocrine therapy—confirmed efficacy and safety

10.1158/1538-7445.sabcs15-p4-13-01 ◽

2016 ◽

Cited By ~ 1

Author(s):

M Cristofanilli ◽

I Bondarenko ◽

J Ro ◽

S-A Im ◽

N Masuda ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Phase 3 ◽

Hormone Receptor Positive

Download Full-text

A Study Evaluating the Efficacy and Safety of GDC-0077 + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04191499 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Hormone Receptor ◽

Locally Advanced ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive

Download Full-text